Anti-CD1a CAR-T

CD1a-targeted chimeric antigen receptor T-cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD1a CAR-T, covering 2023-02-27 to 2023-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma [Phase 2]

See pricing